PlainRecalls
FDA Drug Low Class III Terminated

Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10

Reported: March 25, 2015 Initiated: January 23, 2015 #D-0413-2015

Product Description

Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10

Reason for Recall

Subpotent Drug and Failed Impurities/Degradation Specifications

Details

Recalling Firm
Mylan Institutional LLC
Units Affected
78,090 vials
Distribution
Nationwide
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10. Recalled by Mylan Institutional LLC. Units affected: 78,090 vials.
Why was this product recalled?
Subpotent Drug and Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 25, 2015. Severity: Low. Recall number: D-0413-2015.